江西天新药业股份有限公司关于选举第三届董事会职工代表董事的公告

Core Points - Jiangxi Tianxin Pharmaceutical Co., Ltd. held its first employee representative meeting on September 17, 2025, where Mr. Li Quanguo was elected as the employee representative director for the third board of directors [1][2] - Mr. Li Quanguo's term will last until the end of the current board's term, and he meets all legal qualifications for the position [1][2] - The company confirmed that the number of directors who are also senior management and employee representatives does not exceed half of the total number of directors [1] Meeting Details - The first temporary shareholders' meeting was held on September 17, 2025, at the company's conference room in Le Ping City, Jiangxi Province [4] - The total number of shares eligible for voting at the meeting was 435,170,280, after accounting for shares in the company's repurchase account that do not have voting rights [5] - The meeting was conducted in accordance with the Company Law and the company's articles of association, with both on-site and online voting methods used [5][6] Resolutions Passed - The meeting approved the proposal to abolish the supervisory board and amend the company's articles of association [7] - The first proposal was a special resolution that received more than two-thirds of the valid voting rights held by attending shareholders [7] Legal Verification - The meeting was witnessed by lawyers from Beijing Zhonglun (Shanghai) Law Firm, who confirmed that the meeting's procedures and voting results were in compliance with applicable laws and the company's articles of association [8]